Tag: 上海品茶网RGR

Watchdog asks ethics officials to probe Azar over industry ties and views on rebates

first_img Log In | Learn More Watchdog asks ethics officials to probe Azar over industry ties and views on rebates STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. A watchdog group has asked ethics officials at the Department of Health and Human Services to investigate the relationship between Alex Azar, who heads the department, and Eli Lilly (LLY), his former employer, over a recently proposed rule that would benefit drug makers.The request by the Campaign for Accountability, a nonprofit, comes in response to a proposal the Trump administration is considering to reduce or restrict rebates, which are essentially a type of discount that drug makers provide pharmacy benefit managers off the wholesale, or list, price for their medicines in order to receive favorable placement on formularies, which are lists of insured drugs. About the Author Reprints By Ed Silverman Aug. 28, 2018 Reprints What is it? [email protected] What’s included?center_img Pharmalot Ed Silverman Tags drug pricingpharmaceuticalspolicySTAT+ Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED GET STARTED Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tasos Katopodis/Getty Images @Pharmalot last_img read more